A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Leukemia

• Publication date

  2018-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41375-018-0083-3PMID 29556021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ASXL1 plays an important role in erythropoiesis

  2016cited by this paper
• Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

  2016cited by this paper
• The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination

  2015cited by this paper
• SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.

  2015cited by this paper
• Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells.

  2015cited by this paper
• Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7)

  2015cited by this paper
• The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer*♦

  2015cited by this paper
• Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.

  2015cited by this paper
• Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex

  2015cited by this paper
• TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.

  2014cited by this paper
• Targeting histone methyltransferase EZH2 as cancer treatment.

  2014cited by this paper
• Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

  2014cited by this paper
• Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling*

  2014cited by this paper
• O-GlcNAc and the Epigenetic Regulation of Gene Expression*

  2014cited by this paper
• AP2α transcriptional activity is essential for retinoid-induced neuronal differentiation of mesenchymal stem cells.

  2014cited by this paper
• Marrow failure: a window into ribosome biology.

  2014cited by this paper
• Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.

  2014cited by this paper
• O-GlcNAcylation regulates EZH2 protein stability and function

  2014cited by this paper
• Ten-Eleven Translocation 1 (Tet1) Is Regulated by O-Linked N-Acetylglucosamine Transferase (Ogt) for Target Gene Repression in Mouse Embryonic Stem Cells*

  2013cited by this paper
• O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.

  2013cited by this paper
• TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS

  2013cited by this paper
• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells*

  2013cited by this paper
• Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells.

  2013cited by this paper
• Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.

  2013cited by this paper
• Mixed Lineage Leukemia 5 (MLL5) Protein Regulates Cell Cycle Progression and E2F1-responsive Gene Expression via Association with Host Cell Factor-1 (HCF-1)*

  2013cited by this paper
• Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

  2013cited by this paper
• Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• TET2 promotes histone O-GlcNAcylation during gene transcription

  2012cited by this paper
• Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation

  2012cited by this paper
• ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

  2012cited by this paper
• Unraveling the molecular pathophysiology of myelodysplastic syndromes.

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• O-GlcNAc signalling: implications for cancer cell biology

  2011cited by this paper
• Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.

  2011cited by this paper
• Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

  2011cited by this paper
• Clinical implications of novel mutations in epigenetic modifiers in AML.

  2011cited by this paper
• GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression.

  2010cited by this paper
• Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia.

  2010cited by this paper
• Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

  2009cited by this paper
• Functional Conservation of Asxl2, a Murine Homolog for the Drosophila Enhancer of Trithorax and Polycomb Group Gene Asx

  2009cited by this paper
• The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies.

  2008cited by this paper
• Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia

  2008cited by this paper
• Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

  2007cited by this paper
• The Kruppel‐like factor KLF4 is a critical regulator of monocyte differentiation

  2007cited by this paper
• Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family.

  2006cited by this paper
• O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.

  2004cited by this paper
• A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11.

  2003cited by this paper
• MafB is an inducer of monocytic differentiation

  2000cited by this paper
• The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP

  2000cited by this paper
• Sp1 Cooperates with the ets Transcription Factor, GABP, to Activate the CD18 (β2 Leukocyte Integrin) Promoter*

  1998cited by this paper
• The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes.

  1998cited by this paper
• The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity.

  1993cited by this paper

• Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope.

  2026cites this paper
• The Disordered Region of ASXL1 Acts as an Auto-Regulator Through Condensation.

  2026cites this paper
• ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights

  2025cites this paper
• A mini-review: the role of glycosylation in acute myeloid leukemia and its potential for treatment

  2025cites this paper
• Regulation, functions and therapeutic strategies of H2AK119ub1.

  2025cites this paper
• Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects

  2025cites this paper
• Epigenome-wide DNA methylation association study of CHIP provides insight into perturbed gene regulation

  2025cites this paper
• Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation

  2025cites this paper
• A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia

  2025cites this paper
• A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia

  2025influential citation
• A Zebrafish Seizure Model of cblX Syndrome Reveals a Dose-Dependent Response to mTor Inhibition

  2025cites this paper
• OGT mediated HDAC5 O-GlcNAcylation promotes osteogenesis by regulating the homeostasis of epigenetic modifications and proteolysis

  2024cites this paper
• Clonal hematopoiesis and hematological malignancy

  2024cites this paper
• Analysis of contemporary Russian and foreign approaches to biomonitoring of furan and its derivatives in the human body (literature review)

  2024cites this paper
• Epigenome-wide DNA Methylation Association Study of CHIP Provides Insight into Perturbed Gene Regulation

  2024cites this paper
• Can O-GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?

  2024cites this paper
• Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119

  2024cites this paper
• The role of ASXL1 mutations and ASXL1 CircRNAs in cancer

  2024cites this paper
• Epigenetic regulation by ASXL1 in myeloid malignancies

  2023cites this paper
• The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.

  2023cites this paper
• O-GlcNAcylation: the sweet side of epigenetics

  2023cites this paper
• Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases.

  2023cites this paper
• Upregulation of HCFC1 expression promoted hepatocellular carcinoma progression through inhibiting cell cycle arrest and correlated with immune infiltration

  2023cites this paper
• The role of O-GlcNAcylation in development.

  2023cites this paper
• Missense and nonsense mutations of the zebrafish hcfc1a gene result in contrasting mTor and radial glial phenotypes

  2022cites this paper
• Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.

  2022cites this paper
• Splice variants denote differences between a cancer stem cell side population of EWSR1-ERG-based Ewing sarcoma cells, its main population and EWSR1-FLI-based cells

  2022influential citation
• Intellectual disability-associated disruption of O-GlcNAc cycling impairs habituation learning in Drosophila

  2022cites this paper
• ASXL1/2 mutations and myeloid malignancies

  2022cites this paper
• O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

  2022cites this paper
• Role of ASXL1 in Hematopoiesis and Myeloid Diseases.

  2022cites this paper
• Differential Regulation of mTor signaling defines subtypes of cblX syndrome

  2022cites this paper
• Molecular Pathogenesis of Myeloproliferative Neoplasms

  2022cites this paper
• Clonal hematopoiesis and bone marrow inflammation.

  2022cites this paper
• RINGs, DUBs and Abnormal Brain Growth—Histone H2A Ubiquitination in Brain Development and Disease

  2022cites this paper
• Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish

  2021cites this paper
• Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia

  2021cites this paper
• O-GlcNAcylation links oncogenic signals and cancer epigenetics

  2021cites this paper
• O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers

  2021cites this paper
• Asxl1loss cooperates with oncogenic Nras in mice to reprogram immune microenvironment and drive leukemic transformation.

  2021cites this paper
• Integrative Network Analysis of Cancer Cell Signaling by High-Resolution Proteomics

  2021cites this paper
• Clinical implication and prognostic significance of FLT3-ITD and ASXL1 mutations in Egyptian AML patients: A single-center study

  2021cites this paper
• A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells.

  2021cites this paper
• ReviewO-GlcNAcylation: implications in normal and malignant hematopoiesis.

  2021cites this paper
• O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination

  2021cites this paper
• Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer

  2021cites this paper
• Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers

  2021cites this paper
• Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia

  2021cites this paper
• Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

  2021cites this paper
• O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination

  2021cites this paper
• The Role of ASXL1/2 and Their Associated Proteins in Malignant Hematopoiesis

  2020cites this paper
• O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis

  2020cites this paper
• [The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description].

  2020cites this paper
• Molecular Regulation of the Polycomb Repressive-Deubiquitinase

  2020cites this paper
• Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges

  2020cites this paper
• A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation

  2020cites this paper
• Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia

  2020influential citation
• Clinical implications of recurrent gene mutations in acute myeloid leukemia

  2020cites this paper
• Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate

  2020cites this paper
• ASXL1 mutation in clonal hematopoiesis.

  2020cites this paper
• The role of ASXL1 in hematopoiesis and myeloid malignancies

  2019cites this paper
• Increased expression of O-GlcNAc transferase (OGT) is a biomarker for poor prognosis and allows tumorigenesis and invasion in colon cancer.

  2019cites this paper
• Hcfc1a regulates neural precursor proliferation and asxl1 expression in the developing brain

  2019cites this paper
• Regulation of Polycomb Repression by O-GlcNAcylation: Linking Nutrition to Epigenetic Reprogramming in Embryonic Development and Cancer

  2019cites this paper
• Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation

  2018cites this paper
• Multiple Roles of Glycans in Hematological Malignancies

  2018cites this paper
• ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells

  2018cites this paper
• JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy.

  2018cites this paper
• Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms

  2018cites this paper